Det overdrevne forsvar for en mekanisme som den, der blev indført den 30. august 2003, og som ordret er medtaget i ændringforslaget til TRIPS-aftalen, som EU ønsker at ratificere, viser, at man meget klart har valgt at tage parti for de store multinationale medicinalvirksomheder og overlade millioner af patienter i de fattige lande til deres dødelige sygsomme såsom aids, tuberkulose, malaria og adskillige andre glemte sygdomme uden hverken forskning eller behandling.
Defending to the bitter end a mechanism such as that of 30 August 2003, reproduced word for word in the amendment to the TRIPS agreements that the EU would like to ratify, signifies a very clear choice of sides: it means siding with the large pharmaceutical multinationals and abandoning millions of patients in poor countries to the mercy of diseases that, in their case, are fatal, such as AIDS, tuberculosis, malaria and dozens of other forgotten illnesses, without research or treatment.